Anhui Huaren Health Pharmaceutical Co., Ltd.

XSEC:301408 Stock Report

Market Cap: CN¥4.6b

Anhui Huaren Health Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure8.1yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO

Anhui Huaren Health Pharmaceutical has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Mei Li
CFO, Secretary & Accounting Supervisor6.6yrsCN¥500.00kno data
Jialun He
Deputy General Manager & Director9.7yrsCN¥600.00k6.89%
CN¥ 317.6m
Jun Yin
Deputy General Manager & Director10.9yrsCN¥580.40k0.00045%
CN¥ 20.7k
Chunshui Zhao
Deputy GM & Directorless than a yearCN¥779.50kno data

8.1yrs

Average Tenure

45.5yo

Average Age

Experienced Management: 301408's management team is seasoned and experienced (8.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jialun He
Deputy General Manager & Director9.7yrsCN¥600.00k6.89%
CN¥ 317.6m
Jun Yin
Deputy General Manager & Director10.9yrsCN¥580.40k0.00045%
CN¥ 20.7k
Chunshui Zhao
Deputy GM & Directorless than a yearCN¥779.50kno data
Xu Lu
Director6yrsno datano data
Jiale He
GM & Chairman of the Board10.9yrsCN¥698.90k50.12%
CN¥ 2.3b
Ce Yang
Non-Independent Director1.6yrsno datano data
Lili Li
Chairman of the Supervisory Board6.6yrsno datano data
Fuan Sun
Supervisor4.3yrsno datano data
Juanjuan Wu
Supervisor6.6yrsno datano data
Chuanrun Li
Independent Directorless than a yearno datano data
Liang Liu
Independent Directorless than a yearno datano data
Mou Cheng
Independent Directorless than a yearno datano data

5.1yrs

Average Tenure

43.5yo

Average Age

Experienced Board: 301408's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:09
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anhui Huaren Health Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution